Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL11498048 | 0.78 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL8030995 | 0.76 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL7164576 | 0.73 | — | — | |
| SCHEMBL6685770 | 0.73 | — | — | |
| SCHEMBL10495561 | 0.73 | — | — | |
| SCHEMBL16500480 | 0.73 | — | — | |
| SCHEMBL6703959 | 0.71 | — | — | |
| SCHEMBL527872 | 0.71 | MEN1 (0.30) | — | |
| SCHEMBL6007857 | 0.69 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL9339493 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0436653-A4 | SYNTHESIS OF CAMPTOTHECIN AND ANALOGS THEREOF | — | 1992-01-15 | — | — | EP | claimed |
| EP-0436653-A1 | SYNTHESIS OF CAMPTOTHECIN AND ANALOGS THEREOF | RESEARCH TRIANGLE INSTITUTE (US) | 1991-07-17 | — | — | EP | claimed |
| WO-1990003169-A1 | SYNTHESIS OF CAMPTOTHECIN AND ANALOGS THEREOF | RESEARCH TRIANGLE INSTITUTE (US) | 1990-04-05 | — | — | WO | claimed |
| JP-10331091-A | — | — | None | — | — | JP | disclosed |
| WO-2023276967-A1 | OSMOREGULATOR | 国立大学法人九州大学 | 2023-01-05 | — | — | WO | disclosed |
| US-8071642-B2 | Dimethyl amino ethyl ether psoralens and methods for their production and use | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2011-12-06 | — | — | US | disclosed |
| CN-101466725-A | Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders | SIGMA TAU IND FARMACEUTI (IT) | 2009-06-24 | — | — | CN | disclosed |
| US-20090155224-A1 | Dimethyl amino ethyl ether psoralens and methods for their production and use | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2009-06-18 | — | — | US | disclosed |
| WO-2004024671-A1 | METHOD FOR THE PRODUCTION OF DIALKYL AMINO ETHERS | SASOL GERMANY GMBH (DE) | 2004-03-25 | — | — | WO | disclosed |
| WO-2004024671-A1 | METHOD FOR THE PRODUCTION OF DIALKYL AMINO ETHERS | SASOL GERMANY GMBH (DE) | 2004-03-25 | — | — | WO | disclosed |
| WO-2004024671-A1 | METHOD FOR THE PRODUCTION OF DIALKYL AMINO ETHERS | SASOL GERMANY GMBH (DE) | 2004-03-25 | — | — | WO | disclosed |
| EP-0436653-A4 | SYNTHESIS OF CAMPTOTHECIN AND ANALOGS THEREOF | — | 1992-01-15 | — | — | EP | disclosed |
| EP-0436653-A1 | SYNTHESIS OF CAMPTOTHECIN AND ANALOGS THEREOF | RESEARCH TRIANGLE INSTITUTE (US) | 1991-07-17 | — | — | EP | disclosed |
| US-4981968-A | ENZYME INHIBITORS, ANTITUMOR | RESEARCH TRIANGLE INSTITUTE (US) | 1991-01-01 | — | — | US | disclosed |
| WO-1990003169-A1 | SYNTHESIS OF CAMPTOTHECIN AND ANALOGS THEREOF | RESEARCH TRIANGLE INSTITUTE (US) | 1990-04-05 | — | — | WO | disclosed |
| US-4620037-A | COSMETICS, PHARMACEUTICALS | L'OREAL (FR) | 1986-10-28 | — | — | US | disclosed |
| EP-0158893-A1 | Silane containing isocyanate prepolymers | UNION CARBIDE CORPORATION (US) | 1985-10-23 | — | — | EP | disclosed |
| US-4491534-A | Sequenced surfactant oligomers, process for preparing the same and compositions containing the same | L'OREAL (FR) | 1985-01-01 | — | — | US | disclosed |
| US-4199562-A | USED IN COSMETICS AND DRUGS | L'OREAL (FR) | 1980-04-22 | — | — | US | disclosed |
| US-3838158-A | DIALKYLAMINO ETHERS OF BENZOPYRANOPYRIDINES | SHARPS ASS | 1974-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155224-A1 | Dimethyl amino ethyl ether psoralens and methods for their production and use | HLA-C, HLA-A, HLA-B | ALDH1A1 2269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.